Services & Solutions
One platform, from first
milligram to market.
Discovery synthesis, CMC development, API and drug product manufacturing, analytical science and regulatory dossier preparation for oligonucleotides, peptides and their conjugates.
End-to-end CMC platform
Every phase, one file.
WuXi TIDES oligonucleotide platform provides comprehensive CRDMO services from drug discovery to commercial manufacturing for both drug substance and drug product.
Oligonucleotide
Comprehensive CRDMO services from drug discovery to commercial manufacturing, for both drug substance and drug product.
Oligonucleotide platformPeptide
Linear, cyclic and highly modified peptides — plus UAA, linkers, toxins and peptide conjugates at any scale.
Peptide platformIntegrated CMC
Four disciplines,
one accountable team.
API
Process R&D, API and intermediates manufacturing at any scale.
Drug Product
Pre-formulation, formulation and process development, oral and injectable manufacturing.
Analytical
Method development and validation, quality control, characterisation and stability.
Regulatory CMC
Dossier preparation supporting global regulatory filings for TIDES molecules.
All service pages
Browse the full platform
Drug Product · Clinical Supply
We support parenteral drug product development and manufacturing for oligonucleotide drugs from preclinical to commercial stages.
Open → OligoCandidate Journey
When your oligonucleotide program is on-track toward a New Drug Application (NDA), the last thing you need is CMC delays related to Regulatory Starting Materials (RSMs).
Open → OligoOligonucleotide
WuXi TIDES oligonucleotide platform provides comprehensive CRDMO services from drug discovery to commercial manufacturing for both drug substance and drug product.
Open → OligoOligonucleotide · Development & Manufacturing
Our oligonucleotide API process development and manufacturing platform offers comprehensive services, from preclinical to commercial stages. We’ve established industry-leading capabilities…
Open → OligoOligonucleotide · Development · Analytical
WuXi TIDES has a dedicated analytical team with extensive experience and expertise in oligonucleotide analysis across all development phases from pre-clinical development to commercial…
Open → OligoOligonucleotide · Development · API
Our oligonucleotide API process development and manufacturing platform offers comprehensive services, from preclinical to commercial stages. We’ve established industry-leading capabilities…
Open → OligoOligonucleotide · Development · API · Monomer & Ligand
We provide amidite development and manufacturing services and have dedicated plants for amidite production. Our capacity is more than 10 metric tons/year.
Open → OligoOligonucleotide · Development · Drug Product
We support parenteral drug product development and manufacturing for oligonucleotide drugs from preclinical to commercial stages.
Open → OligoOligonucleotide · Discovery
Our oligonucleotide drug discovery platform is equipped with experienced scientists and state-of-the-art facilities to support your discovery synthesis of oligonucleotides, complex…
Open → OligoOligonucleotide · Discovery · Custom Synthesis
Our oligonucleotide drug discovery platform is equipped with experienced scientists and state-of-the-art facilities to support your discovery synthesis of oligonucleotides, complex…
Open → OligoOligonucleotide · Discovery · Monomer & Ligand
Our team has extensive experience with 1,000+ customized amidite molecules with most challenging structures, to support your oligonucleotide discovery projects. Additionally, we offer 500+…
Open → OligoOligonucleotide · Discovery · Conjugate
Oligonucleotide conjugates create opportunities to deliver the oligonucleotide to a specific cell or tissue and to fine-tune ‘drug-like’ properties. However, the complexity of the…
Open → PeptidePeptide
WuXi TIDES’s peptide platform offers comprehensive CRDMO from drug discovery to commercial manufacturing for both drug substance and drug product.
Open → PeptidePeptide · Discovery
WuXi TIDES peptide discovery platform provides library screening and cusom synthesis to address your needs and offer flexible options for various scales, purity levels, modifications…
Open → PeptidePeptide · Discovery · Custom Synthesis
WuXi TIDES peptide discovery platform provides library screening and cusom synthesis to address your needs and offer flexible options for various scales, purity levels, modifications…
Open → PeptidePeptide · Discovery · Conjugate
Peptide conjugation is a rapidly expanding field, offering a new modality for targeted drug delivery. This approach enhances efficacy and reduces side effects in cancer treatment. Our…
Open → PeptidePeptide · Discovery · Unnatural Amino Acid
We are experts in synthesizing a wide variety of unnatural amino acids (UAA), including the most challenging structures, tailored to our customers’ specifications at all stages. We offer…
Open → PeptidePeptide · Development & Manufacturing
Our peptide API process development and manufacturing platform provides an end-to-end solution from preclinical to commercial stages. We have built industry-leading capabilities and…
Open → PeptidePeptide · Development · Analytical
WuXi TIDES has a dedicated analytical team with extensive experience and expertise in peptide analysis across all development phases from pre-clinical development to commercial…
Open → PeptidePeptide · Development · API
Our peptide API process development and manufacturing platform provides an end-to-end solution from preclinical to commercial stages. We have built industry-leading capabilities and…
Open → PeptidePeptide · Development · API · PPMO
WuXi TIDES’s peptide platform offers comprehensive CRDMO from drug discovery to commercial manufacturing for both drug substance and drug product.
Open → PeptidePeptide · Development · Drug Product
We support both oral and parenteral drug product development and manufacturing for peptide drugs from preclinical to commercial stages.
Open → PlatformRegulatory Dossier Preparation
Our global regulatory dossier preparation teams have extensive experience in global filings for IND, IMPD, and NDA submissions with the US FDA, EMA, and China’s NMPA. By integrating CMC…
Open →How can we help?
Our TIDES drug experts stand ready.
Tell us where your molecule is today — discovery, CMC, or commercial supply — and we will map the fastest credible route to patients.
Small molecule projects? WuXi STA